Literature DB >> 33839947

Monocyte-based inflammatory indices predict outcomes following aneurysmal subarachnoid hemorrhage.

James Feghali1, Jennifer Kim1, Abhishek Gami1, Sarah Rapaport1, Justin M Caplan1, Cameron G McDougall1, Judy Huang1, Rafael J Tamargo1, Christopher M Jackson2.   

Abstract

The contribution of specific immune cell populations to the post-hemorrhagic inflammatory response in aneurysmal subarachnoid hemorrhage (aSAH) and correlations with clinical outcomes, such as vasospasm and functional status, remains unclear. We aimed to compare the predictive value of leukocyte ratios that include monocytes as compared to the neutrophil-to-lymphocyte ratio (NLR) in aSAH. A prospectively accrued database of consecutive patients presenting to our institution with aSAH between January 2013 and December 2018 was used. Patients with signs and symptoms of infection (day 1-3) were excluded. Admission values of the NLR, monocyte-neutrophil-to-lymphocyte ratio (M-NLR), and lymphocyte-to-monocyte ratio (LMR) were calculated. Associations with functional status, the primary outcome, and vasospasm were evaluated using univariable and multivariable logistic regression analyses. In the cohort of 234 patients with aSAH, the M-NLR and LMR, but not the NLR, were significantly associated with poor functional status (modified Rankin scale > 2) at 12-18 months following discharge (p = 0.001, p = 0.023, p = 0.161, respectively). The area under the curve for predicting poor functional status was significantly lower for the NLR (0.543) compared with the M-NLR (0.603, p = 0.024) and LMR (0.608, p = 0.040). The M-NLR (OR = 1.01 [1.01-1.02]) and LMR (OR = 0.88 [0.78-0.99]) were independently associated with poor functional status while controlling for age, hypertension, Fisher grade, and baseline clinical status. The LMR was significantly associated with vasospasm (OR = 0.84 [0.70-0.99]) while adjusting for age, hypertension, Fisher grade, aneurysm size, and current smoking. Inflammatory indices that incorporate monocytes (e.g., M-NLR and LMR), but not those that include only neutrophils, predict outcomes after aSAH.

Entities:  

Keywords:  Inflammation; Intracranial aneurysm; Subarachnoid hemorrhage

Year:  2021        PMID: 33839947     DOI: 10.1007/s10143-021-01525-1

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  40 in total

1.  Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.

Authors:  Antje Giede-Jeppe; Jonathan Reichl; Maximilian I Sprügel; Hannes Lücking; Philip Hoelter; Ilker Y Eyüpoglu; Joji B Kuramatsu; Hagen B Huttner; Stefan T Gerner
Journal:  J Neurosurg       Date:  2019-02-01       Impact factor: 5.115

2.  Admission neutrophil-lymphocyte ratio predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.

Authors:  Fawaz Al-Mufti; Krishna Amuluru; Nitesh Damodara; Vincent Dodson; David Roh; Sachin Agarwal; Philip M Meyers; E Sander Connolly; Michael J Schmidt; Jan Claassen; Soojin Park
Journal:  J Neurointerv Surg       Date:  2019-04-12       Impact factor: 5.836

3.  Endothelin-1 in subarachnoid hemorrhage: An acute-phase reactant produced by cerebrospinal fluid leukocytes.

Authors:  K Fassbender; B Hodapp; S Rossol; T Bertsch; J Schmeck; S Schütt; M Fritzinger; P Horn; P Vajkoczy; M Wendel-Wellner; A Ragoschke; S Kuehl; J Brunner; L Schürer; P Schmiedeck; M Hennerici
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

4.  Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage.

Authors:  Kaisorn L Chaichana; Andrew P Levy; Rachel Miller-Lotan; Sophia Shakur; Rafael J Tamargo
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

Review 5.  Early brain injury, an evolving frontier in subarachnoid hemorrhage research.

Authors:  Mutsumi Fujii; Junhao Yan; William B Rolland; Yoshiteru Soejima; Basak Caner; John H Zhang
Journal:  Transl Stroke Res       Date:  2013-08       Impact factor: 6.829

Review 6.  Implications of macrophage polarization in autoimmunity.

Authors:  Samanta C Funes; Mariana Rios; Jorge Escobar-Vera; Alexis M Kalergis
Journal:  Immunology       Date:  2018-03-08       Impact factor: 7.397

7.  Admission Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker of Outcomes in Large Vessel Occlusion Strokes.

Authors:  Nitin Goyal; Georgios Tsivgoulis; Jason J Chang; Konark Malhotra; Abhi Pandhi; Muhammad F Ishfaq; Diana Alsbrook; Adam S Arthur; Lucas Elijovich; Andrei V Alexandrov
Journal:  Stroke       Date:  2018-08       Impact factor: 7.914

8.  The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.

Authors:  Nima Etminan; Robert D Brown; Kerim Beseoglu; Seppo Juvela; Jean Raymond; Akio Morita; James C Torner; Colin P Derdeyn; Andreas Raabe; J Mocco; Miikka Korja; Amr Abdulazim; Sepideh Amin-Hanjani; Rustam Al-Shahi Salman; Daniel L Barrow; Joshua Bederson; Alain Bonafe; Aaron S Dumont; David J Fiorella; Andreas Gruber; Graeme J Hankey; David M Hasan; Brian L Hoh; Pascal Jabbour; Hidetoshi Kasuya; Michael E Kelly; Peter J Kirkpatrick; Neville Knuckey; Timo Koivisto; Timo Krings; Michael T Lawton; Thomas R Marotta; Stephan A Mayer; Edward Mee; Vitor Mendes Pereira; Andrew Molyneux; Michael K Morgan; Kentaro Mori; Yuichi Murayama; Shinji Nagahiro; Naoki Nakayama; Mika Niemelä; Christopher S Ogilvy; Laurent Pierot; Alejandro A Rabinstein; Yvo B W E M Roos; Jaakko Rinne; Robert H Rosenwasser; Antti Ronkainen; Karl Schaller; Volker Seifert; Robert A Solomon; Julian Spears; Hans-Jakob Steiger; Mervyn D I Vergouwen; Isabel Wanke; Marieke J H Wermer; George K C Wong; John H Wong; Gregory J Zipfel; E Sander Connolly; Helmuth Steinmetz; Giuseppe Lanzino; Alberto Pasqualin; Daniel Rüfenacht; Peter Vajkoczy; Cameron McDougall; Daniel Hänggi; Peter LeRoux; Gabriel J E Rinkel; R Loch Macdonald
Journal:  Neurology       Date:  2015-08-14       Impact factor: 9.910

9.  Innate immunity activation in the early brain injury period following subarachnoid hemorrhage.

Authors:  Typhaine Gris; Patrick Laplante; Paméla Thebault; Romain Cayrol; Ahmed Najjar; Benjamin Joannette-Pilon; Frédéric Brillant-Marquis; Elsa Magro; Shane W English; Réjean Lapointe; Michel Bojanowski; Charles L Francoeur; Jean-François Cailhier
Journal:  J Neuroinflammation       Date:  2019-12-04       Impact factor: 8.322

10.  The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.

Authors:  Ross D Dolan; Jason Lim; Stephen T McSorley; Paul G Horgan; Donald C McMillan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more
  4 in total

1.  A 90-Day Prognostic Model Based on the Early Brain Injury Indicators after Aneurysmal Subarachnoid Hemorrhage: the TAPS Score.

Authors:  Runting Li; Fa Lin; Yu Chen; Junlin Lu; Heze Han; Li Ma; Yahui Zhao; Debin Yan; Ruinan Li; Jun Yang; Shihao He; Zhipeng Li; Haibin Zhang; Kexin Yuan; Ke Wang; Qiang Hao; Xun Ye; Hao Wang; Hongliang Li; Linlin Zhang; Guangzhi Shi; Jianxin Zhou; Yang Zhao; Yukun Zhang; Youxiang Li; Shuo Wang; Xiaolin Chen; Yuanli Zhao
Journal:  Transl Stroke Res       Date:  2022-05-14       Impact factor: 6.829

2.  Monocyte Count on Admission Is Predictive of Shunt-Dependent Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Joshua A Cuoco; Evin L Guilliams; Brendan J Klein; Mark R Witcher; Eric A Marvin; Biraj M Patel; John J Entwistle
Journal:  Front Surg       Date:  2022-04-28

3.  Exploration of Risk Factors for Poor Prognosis of Non-Traumatic Non-Aneurysmal Subarachnoid Hemorrhage.

Authors:  Yuan Yuan; Jingjiong Chen; Yaxuan Zhang; Fei Zhao; Yanyu Zhai; Xiaofeng Xu; Lixia Xue; Yuwu Zhao; Hongmei Wang
Journal:  Biomolecules       Date:  2022-07-06

4.  The lymphocyte-to-monocyte ratio predicts intracranial atherosclerotic stenosis plaque instability.

Authors:  Xiao-Bing Wu; Li-Xin Huang; Zhong-Run Huang; Li-Ming Lu; Bin Luo; Wang-Qing Cai; An-Min Liu; Sheng-Wen Wang
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.